glp-1 obesity drug news today oct 23 2025 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Use of diabetes and anti-obesity

Learn the most common side effects of GLP-1 medications, like nausea, fatigue and reflux, and find tips to manage them effectively.

This analysis of survey data finds that over 40% of adults under 65 with private insurance could be indicated for a GLP-1 drug though relatively few have a claim, suggesting that a much smaller share seeks treatment through healthcare providers.

This article examines clinical evidence for combination therapy, safety profiles, and how genetic predispositions in GLP-1 and glucose metabolism pathways may info

New data is illuminating the full profile of GLP-1 side effects

GLP-1R agonist 2 (compound 2) is an effective GLP-1R agonist that exerts its activating effect by forming hydrogen bonds with the Tyr42, Cys71, and Ser84 residues of GLP-1R

Lindsay R